CIMAi001-A

A P E C

The cell line is not submitted yet.

(only basic data is shown)

iPSC Line
hPSCreg name	CIMAi001-A
Cite as:	CIMAi001-A (RRID:CVCL_YC91)
iPSC line type	Human induced pluripotent stem cell (hiPSC)
Similar iPSC lines	No similar lines found.
Last update	21st October 2019
User feedback	Written by on No feedback available yet. Login to share your feedback, experiences or results with the research community.
Provider
Generator	CIMA Universidad de Navarra (CIMA)
External iPSC Databases
Cellosaurus	CVCL_YC91
Wikidata	Q93453553
General iPSC Information
Publications	Martinez-Turrillas R et al. Generation of an induced pluripotent stem cell line (CIMAi001-A) from a compound heterozygous Primary Hyperoxaluria Type I (PH1) patient carrying p.G170R and p.R122* mutations in the AGXT gene. Stem cell research. 2019 Dec;41:101626. Moya-Garzon MD et al. Small Molecule-Based Enzyme Inhibitors in the Treatment of Primary Hyperoxalurias. Journal of personalized medicine. 2021 Jan 27;11(2). Hoppe B et al. Improving Treatment Options for Primary Hyperoxaluria. Drugs. 2022 Jul;82(10):1077-1094. Beck Bodo B. et al. Primary Hyperoxaluria. Pediatric Kidney Disease. 2023-00-00. Vicente Pedro et al. Oxygen control in bioreactor drives high yield production of functional hiPSC-like hepatocytes for advanced liver disease modelling. Scientific Reports. 2024-10-19.